This is a serious multisystem disease in which few patients survive to adulthood. Weakness, unsteadiness, recurrent fevers, floppy muscles, anemia and developmental delays are important features. The lymph nodes, liver, and spleen are enlarged and there is an increased susceptibility to infections.
MVK is a severe enzymatic deficiency causing multi-organ disease. Hypotonia, ataxia, motor delay, anemia, and hepatosplenomegaly with lymphadenopathy are early and important features but recurrent fever is the most unusual. Some patients have fat malabsorptive enteropathy as well. Increased levels of mevalonic acid in urine are diagnostic.
Mevalonate kinase deficiency is caused by a mutation in the MVK gene located on chromosome 12 (12q24). This kinase is an important link in cholesterol and isoprenoid synthesis. Multiple mutations have been found including 803T>C and 1174G<A mutations in the Mennonite community of Southeastern Pennsylvania. There is some suggestion of clustering of these mutations. This is likely an autosomal recessive disease but no large pedigrees have been published. Compound heterozygosity seems to be common.
None has been found. Attempts to inhibit the precursor reductase to lower tissue levels of mevalonic acid has led to patient decompensation suggesting that its accumulation is not responsible for the clinical manifestations.
General support as needed.
Few patients live to become adults.
Pediatrician, neurologist, infectious disease, ophthalmologist.
Hinson, D.D., Ross, R.M., Krisans, S., Shaw, J.L., Kozich, V., Rolland, M.-O., Divry, P., Mancini, J., Hoffmann, G.F., and Gibson, K.M.: Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. A. J. Hum. Genet. 65: 327-335, 1999. PubMed ID: 10417275
Mandey, S.H.L., Schneiders, M.S., Koster, J., and Waterham, H.R.: Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum. Mutat. 27: 796-802, 2006. PubMed ID: 16835861